IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WASAN CARTWRIGHT

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1073123063
CMS profile
10453833
Location
ALBUQUERQUE, NM

General Payments · PY2021–2024

$2,506.20

  • Reported across 102 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,405.22

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family NM All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,405.22 54

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $473.74 11
Regeneron Healthcare Solutions, Inc. $206.47 9
GENZYME CORPORATION $146.79 6
Grifols USA, LLC $116.34 7
Genentech USA, Inc. $108.68 4
CSL Behring $103.37 4
Incyte Corporation $68.05 4
Takeda Pharmaceuticals U.S.A., Inc. $58.12 3
Amgen Inc. $48.07 2
BioCryst US Sales Co., LLC $39.12 2
NOVARTIS PHARMACEUTICALS CORPORATION $20.03 1
AERIN MEDICAL INC. $16.44 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $39.55 2
PY2022 $59.25 4
PY2023 $1,002.18 42
PY2024 $1,405.22 54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AERIN MEDICAL INC. $16.44 10/28/2024 Food and Beverage Undisputed 01/23/2026 1144646423 CMS
Amgen Inc. $22.62 02/15/2024 Food and Beverage Undisputed 01/23/2026 1117219316 CMS
Amgen Inc. $25.45 04/03/2024 Food and Beverage Undisputed 01/23/2026 1117219318 CMS
AstraZeneca Pharmaceuticals LP $304.30 01/09/2024 Food and Beverage Undisputed 01/23/2026 1105860522 CMS
AstraZeneca Pharmaceuticals LP $17.78 02/08/2024 Food and Beverage Undisputed 01/23/2026 1105542955 CMS
AstraZeneca Pharmaceuticals LP $14.49 02/23/2024 Food and Beverage Undisputed 01/23/2026 1105755689 CMS
AstraZeneca Pharmaceuticals LP $15.29 03/20/2024 Food and Beverage Undisputed 01/23/2026 1104225279 CMS
AstraZeneca Pharmaceuticals LP $14.96 03/27/2024 Food and Beverage Undisputed 01/23/2026 1104621678 CMS
AstraZeneca Pharmaceuticals LP $18.57 04/30/2024 Food and Beverage Undisputed 01/23/2026 1104682081 CMS
AstraZeneca Pharmaceuticals LP $18.08 06/04/2024 Food and Beverage Undisputed 01/23/2026 1104536393 CMS
AstraZeneca Pharmaceuticals LP $16.75 07/16/2024 Food and Beverage Undisputed 01/23/2026 1104660229 CMS
AstraZeneca Pharmaceuticals LP $13.12 07/26/2024 Food and Beverage Undisputed 01/23/2026 1105418690 CMS
AstraZeneca Pharmaceuticals LP $27.15 08/08/2024 Food and Beverage Undisputed 01/23/2026 1104679417 CMS
AstraZeneca Pharmaceuticals LP $13.25 10/30/2024 Food and Beverage Undisputed 01/23/2026 1105461738 CMS
BioCryst US Sales Co., LLC $18.94 03/06/2024 Food and Beverage Undisputed 01/23/2026 1117469495 CMS
BioCryst US Sales Co., LLC $20.18 11/06/2024 Food and Beverage Undisputed 01/23/2026 1117475636 CMS
CSL Behring $19.17 03/22/2024 Food and Beverage Undisputed 01/23/2026 1134657359 CMS
CSL Behring $36.78 06/05/2024 Food and Beverage Undisputed 01/23/2026 1134657387 CMS
CSL Behring $23.71 07/18/2024 Food and Beverage Undisputed 01/23/2026 1134657397 CMS
CSL Behring $23.71 08/26/2024 Food and Beverage Undisputed 01/23/2026 1134657405 CMS
Genentech USA, Inc. $30.93 03/08/2024 Food and Beverage Undisputed 01/23/2026 1133194208 CMS
Genentech USA, Inc. $21.94 04/10/2024 Food and Beverage Undisputed 01/23/2026 1133194204 CMS
Genentech USA, Inc. $30.80 05/29/2024 Food and Beverage Undisputed 01/23/2026 1133194212 CMS
Genentech USA, Inc. $25.01 09/04/2024 Food and Beverage Undisputed 01/23/2026 1133194217 CMS
GENZYME CORPORATION $21.37 02/28/2024 Food and Beverage Undisputed 01/23/2026 1139925987 CMS
GENZYME CORPORATION $18.14 04/11/2024 Food and Beverage Undisputed 01/23/2026 1139925999 CMS
GENZYME CORPORATION $17.51 05/23/2024 Food and Beverage Undisputed 01/23/2026 1139926011 CMS
GENZYME CORPORATION $22.98 07/02/2024 Food and Beverage Undisputed 01/23/2026 1139926031 CMS
GENZYME CORPORATION $32.76 09/25/2024 Food and Beverage Undisputed 01/23/2026 1139926049 CMS
GENZYME CORPORATION $34.03 11/12/2024 Food and Beverage Undisputed 01/23/2026 1139926063 CMS
Grifols USA, LLC $17.54 01/18/2024 Food and Beverage Undisputed 01/23/2026 1124753308 CMS
Grifols USA, LLC $19.87 03/07/2024 Food and Beverage Undisputed 01/23/2026 1124753306 CMS
Grifols USA, LLC $19.87 05/09/2024 Food and Beverage Undisputed 01/23/2026 1124753300 CMS
Grifols USA, LLC $17.65 05/30/2024 Food and Beverage Undisputed 01/23/2026 1124753302 CMS
Grifols USA, LLC $13.31 06/27/2024 Food and Beverage Undisputed 01/23/2026 1124753298 CMS
Grifols USA, LLC $14.05 08/15/2024 Food and Beverage Undisputed 01/23/2026 1124753304 CMS
Grifols USA, LLC $14.05 11/14/2024 Food and Beverage Undisputed 01/23/2026 1124753310 CMS
Incyte Corporation $13.17 01/30/2024 Food and Beverage Undisputed 01/23/2026 1141189325 CMS
Incyte Corporation $20.75 03/22/2024 Food and Beverage Undisputed 01/23/2026 1141234353 CMS
Incyte Corporation $19.03 06/13/2024 Food and Beverage Undisputed 01/23/2026 1141190219 CMS
Incyte Corporation $15.10 08/29/2024 Food and Beverage Undisputed 01/23/2026 1141236601 CMS
Novartis Pharmaceuticals Corporation $20.03 02/09/2024 Food and Beverage Undisputed 01/23/2026 1086774473 CMS
Regeneron Healthcare Solutions, Inc. $19.24 02/01/2024 Food and Beverage Undisputed 01/23/2026 1114281824 CMS
Regeneron Healthcare Solutions, Inc. $23.81 02/14/2024 Food and Beverage Undisputed 01/23/2026 1114281826 CMS
Regeneron Healthcare Solutions, Inc. $21.03 04/16/2024 Food and Beverage Undisputed 01/23/2026 1114281828 CMS
Regeneron Healthcare Solutions, Inc. $20.58 05/16/2024 Food and Beverage Undisputed 01/23/2026 1114281830 CMS
Regeneron Healthcare Solutions, Inc. $27.61 07/17/2024 Food and Beverage Undisputed 01/23/2026 1114281832 CMS
Regeneron Healthcare Solutions, Inc. $31.60 08/01/2024 Food and Beverage Undisputed 01/23/2026 1114281834 CMS
Regeneron Healthcare Solutions, Inc. $26.15 08/28/2024 Food and Beverage Undisputed 01/23/2026 1114281836 CMS
Regeneron Healthcare Solutions, Inc. $17.01 10/02/2024 Food and Beverage Undisputed 01/23/2026 1114281838 CMS
Regeneron Healthcare Solutions, Inc. $19.44 10/08/2024 Food and Beverage Undisputed 01/23/2026 1114281840 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.94 07/02/2024 Food and Beverage Undisputed 01/23/2026 1137723350 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.53 10/10/2024 Food and Beverage Undisputed 01/23/2026 1137723352 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.65 10/10/2024 Food and Beverage Undisputed 01/23/2026 1137723354 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.